NCT00228150 - Study of the Effect of SR57667B on the Progression of Symptoms in Patients With Parkinson's Disease | Biotech Hunter

Enrollment

564

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

April 30, 2006

Study Completion Date

April 30, 2006

Conditions

Parkinson Disease

Interventions

DRUG

SR57667B

Trial Locations (13)

Sanofi-Aventis Administrative Office, Vienna

Sanofi-Aventis Administrative Office, Laval

Sanofi-Aventis Administrative Office, Hørsholm

Sanofi-Aventis Administrative Office, Paris

Sanofi-Aventis Administrative Office, Berlin

Sanofi-Aventis Administrative Office, Casablanca

Sanofi-Aventis Administrative Office, Gouda

Sanofi-Aventis Administrative Office, Porto Salvo

Sanofi-Aventis Administrative Office, Midrand

Sanofi-Aventis Administrative Office, Barcelona

Sanofi-Aventis Administrative Office, Bromma

Sanofi-Aventis Administrative Office, Mégrine

Sanofi-Aventis Administrative Office, Guilford Surrey